Labcorp Holdings Inc. (LH) — Fair Value Analysis
Base-case fair value (P50): $254.50 · Current price: $256.55 · Verdict: Fairly Valued
The Verdict on LH
Our Monte Carlo simulations indicate that LabCorp (LH), a key player in the Healthcare sector, is Fairly Valued. The current market price of $256.55 closely aligns with our median fair value (P50) of $254.50, suggesting the market has efficiently priced the stock based on current fundamentals. This close alignment results in an -0.8% variance, underscoring the present equilibrium between market price and intrinsic value as determined by our forward-looking models. Investors seeking significant mispricings may find LH's current valuation offers limited immediate arbitrage opportunities.
How LH stacks up against Healthcare
LabCorp (LH) currently holds an "average" quality tier when assessed against its Healthcare sector peers. This designation reflects its operational and financial health, suggesting performance metrics generally in line with the broader industry. The Monte Carlo simulations, in conjunction with this average quality tier, reinforce the Fairly Valued verdict. A company with average quality, whose $256.55 is nearly identical to its $254.50, often implies a market consensus that fully incorporates its fundamental profile without significant premiums or discounts. The -0.8% further supports this view of a well-balanced valuation within the Healthcare landscape.
What this means for investors
For investors, LabCorp's (LH) Fairly Valued status, where $256.55 is almost perfectly matched with $254.50 and exhibits an -0.8% spread, signals a mature and efficient valuation. Given LH's "average" quality tier, the current price is a robust reflection of its underlying value derived from thousands of Monte Carlo scenarios. While the stock may not offer substantial alpha purely from a valuation gap today, its fair value is dynamic and subject to change with new financial releases and market developments. Sign up for FairCurve to see the full bear/bull distribution and track LH's fair value as new fundamentals are released.
Frequently Asked Questions
Is LH overvalued or undervalued right now?
LabCorp (LH) is currently fairly valued. Our Monte Carlo simulations show its median fair value of $254.50 is very close to its $256.55, indicating a balanced valuation.
What is the bear case and bull case for LH?
The full Monte Carlo simulation distribution, including specific bear-case (P10) and bull-case (P90) price targets, as well as the probability of achieving upside, is exclusively available to FairCurve account holders. Sign up for free to access these detailed scenarios.
How does FairCurve calculate LH's fair value?
FairCurve calculates LabCorp's fair value through sophisticated Monte Carlo simulations, running thousands of forward-looking scenarios to project a comprehensive range of potential outcomes for the company's financials.
How can I track LH's fair value as it changes?
Add LabCorp (LH) to your free FairCurve watchlist to receive daily fair-value updates. Our system instantly re-evaluates LH's fair value whenever new fundamental data, such as earnings reports, is released.